We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
70 hedge funds and large institutions have $374M invested in Atara Biotherapeutics in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
76% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 17
17% less funds holding
Funds holding: 84 → 70 (-14)
27% less capital invested
Capital invested by funds: $508M → $374M (-$135M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
74% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 19
Holders
70
Holders Change
-14
Holders Change %
-16.67%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
5
Increased
30
Reduced
17
Closed
19
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$886K
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$6.03M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.54M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.51M |
| 4 |
Morgan Stanley
New York
|
-$2.16M |
| 5 |
VAM
Visium Asset Management
New York
|
-$2.1M |
